BSS is a Ophthalmic Solution in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Sodium Chloride; Potassium Chloride; Calcium Chloride; Magnesium Chloride; Sodium Acetate; Sodium Citrate.
Product ID | 0065-1795_4618b4eb-bfc6-b49a-034f-cf332b1461c4 |
NDC | 0065-1795 |
Product Type | Human Prescription Drug |
Proprietary Name | BSS |
Generic Name | Balanced Salt Solution |
Dosage Form | Solution |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 1969-03-28 |
Marketing Category | NDA / NDA |
Application Number | NDA020742 |
Labeler Name | Alcon Laboratories, Inc. |
Substance Name | SODIUM CHLORIDE; POTASSIUM CHLORIDE; CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; SODIUM ACETATE; SODIUM CITRATE |
Active Ingredient Strength | 6 mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL |
Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 1969-03-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020742 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1969-03-28 |
Ingredient | Strength |
---|---|
SODIUM CHLORIDE | 6.4 mg/mL |
SPL SET ID: | 28488c7b-cf6a-4a03-916f-cc66b3afdc57 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0065-0795 | BSS | balanced salt solution |
0065-1795 | BSS | balanced salt solution |